「17α-Dihydroequilin」の版間の差分
ナビゲーションに移動
検索に移動
bsd>OAbot 細 (Open access bot: doi added to citation with #oabot.) |
細 (1版 をインポートしました) |
(相違点なし)
| |
2025年3月18日 (火) 19:26時点における最新版
| ファイル:17α Dihydroequilin.svg | |
|---|---|
| Systematic (IUPAC) name | |
| (9S,13S,14S,17R)-13-methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthrene-3,17-diol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | By mouth |
| Identifiers | |
| CAS number | 651-55-8 |
| ATC code | G03CA57 |
| PubChem | CID 9547222 |
| ChemSpider | 7826162 |
| UNII | 48P73794OJ |
| Synonyms | α-Dihydroequilin; 7-Dehydro-17α-estradiol; Estra-1,3,5(10),7-tetraen-3,17α-diol |
| Chemical data | |
| Formula | C18H22O2 |
| |
17α-Dihydroequilin, or α-dihydroequilin, also known as 7-dehydro-17α-estradiol, as well as estra-1,3,5(10),7-tetraene-3,17α-diol, is a naturally occurring steroidal estrogen found in horses which is closely related to equilin, equilenin, and 17α-estradiol.[1][2] The compound, as the 3-sulfate ester sodium salt, is present in conjugated estrogens (Premarin), a pharmaceutical extract of the urine of pregnant mares, and is the third highest quantity constituent in the formulation (13.8%).[1] The compound has been studied clinically.[3]
See also
References
- ↑ 以下の位置に戻る: 1.0 1.1 Fritz MA, Speroff L (28 March 2012). Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. pp. 751–. ISBN 978-1-4511-4847-3.
- ↑ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 378–. ISBN 978-92-832-1291-1.
- ↑ Wilcox JG, Stanczyk FZ, Morris RS, Gentzschein E, Lobo RA (November 1996). "Biologic effects of 17 alpha-dihydroequilin sulfate". Fertility and Sterility. 66 (5): 748–52. doi:10.1016/S0015-0282(16)58629-4. PMID 8893678.
| ||
| ||